AMN Healthcare/$AMN
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About AMN Healthcare
AMN Healthcare Services Inc provides healthcare workforce solutions and staffing services in the United States. Its comprehensive suite of talent solutions provides management, staffing, recruitment, language services, technology, predictive and market analytics, and related services to build and manage all or parts of the clients' healthcare workforce needs. Its reportable segments are: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. A majority of its revenue is generated from the Nurse and Allied Solutions segment, which includes the company's travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, and allied staffing (including revenue cycle solutions) businesses.
- Ticker
- $AMN
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 2,664
- Headquarters
- Dallas, United States
- Website
- www.amnhealthcare.com
AMN Healthcare Metrics
BasicAdvanced
$1.8B
17.50
$2.69
0.39
-
Price and volume
Market cap
$1.8B
Beta
0.39
52-week high
$49.62
52-week low
$14.97
Average daily volume
828K
Financial strength
Current ratio
1.128
Quick ratio
1.021
Long term debt to equity
1.039
Total debt to equity
1.002
Interest coverage (TTM)
4.51%
Profitability
EBITDA (TTM)
307.293
Gross margin (TTM)
27.79%
Net profit margin (TTM)
3.05%
Operating margin (TTM)
4.68%
Effective tax rate (TTM)
36.10%
Revenue per employee (TTM)
$1,290,000
Management effectiveness
Return on assets (TTM)
4.39%
Return on equity (TTM)
15.56%
Valuation
Price to earnings (TTM)
17.504
Price to revenue (TTM)
0.533
Price to book
2.48
Price to tangible book (TTM)
-6.86
Price to free cash flow (TTM)
4.17
Free cash flow yield (TTM)
23.98%
Free cash flow per share (TTM)
11.299
Growth
Revenue change (TTM)
23.99%
Earnings per share change (TTM)
-134.58%
3-year revenue growth (CAGR)
-7.80%
10-year revenue growth (CAGR)
7.12%
3-year earnings per share growth (CAGR)
-29.19%
10-year earnings per share growth (CAGR)
2.24%
What the Analysts think about AMN Healthcare
Analyst ratings (Buy, Hold, Sell) for AMN Healthcare stock.
Analyst projections of the future price of AMN Healthcare stock.
Bulls say / Bears say
Travel nursing and allied staffing are recovering: Q2 revenue rose 10% and 8% respectively, while AMN expects Nurse and Allied revenue to grow 9%–11% year on year in Q3. Management also reported accelerating orders and more than 10% expected volume growth in both businesses. (AMN Healthcare)
Search is adding a separate growth engine: revenue rose 27% year on year in Q2, with strength in physician and executive search. That helps offset weakness in other physician and leadership services. (AMN Healthcare)
Long-term staffing shortages support demand for AMN’s services. The company’s August workforce report projects a US physician shortage of up to 86,000 by 2036 and finds nursing fill rates have fallen in recent years. (AMN Healthcare)
Q2 profitability was boosted by about $27 million of non-recurring revenue adjustments, which added roughly 3.7 percentage points to adjusted EBITDA margin. AMN guided to a 6.5%–7% adjusted EBITDA margin for Q3, well below Q2’s reported 10.9%. (The Motley Fool)
Weakness outside Nurse and Allied remains broad: Q2 Physician and Leadership revenue fell 6% and Technology and Workforce fell 15%. AMN expects those segments to decline another 5%–7% and 11%–13% respectively in Q3. (AMN Healthcare)
Pricing competition could limit the benefit of stronger staffing demand. Language-services pricing fell 8% year on year, while management said travel nurse bill rates had yet to show sustained increases and a larger supplier base was intensifying competition. (The Motley Fool)
Data summarised monthly by Lightyear AI. Last updated on 28 Oct 2026.
AMN Healthcare Financial Performance
Revenues and expenses
AMN Healthcare Earnings Performance
Company profitability
Upcoming events
No upcoming events
AMN Healthcare News
AllArticlesVideos
Funds containing AMN Healthcare
Fund name | Fund size | $AMN weighting |
|---|---|---|
iShares Ageing Population$AGED | $953M | 0.16% |
iShares Ageing Population£AGES | $953M | 0.16% |
iShares Ageing Population€AGED | $903M | 0.16% |
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.10% |
iShares S&P Small Cap 600£ISP6 | $3.2B | 0.10% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.